Piper Sandler analyst Arvind Ramnani maintains Intapp (NASDAQ:INTA) with a Overweight and raises the price target from $19 to $26.
Analyst Ratings for Immunocore Hldgs
Immunocore Hldgs (NASDAQ:IMCR) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…